Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets
Small Methods · 2026
DOI: 10.1002/smtd.71075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2026. Verfasst von Ram J Tharu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University At Albany, State University of New York, Albany, New York, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, CRISPR-Cas Systems, CRISPR-Associated Proteins, Endodeoxyribonucleases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
The programmability of CRISPR‐Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non‐nucleic‐acid targets remains highly desirable. Here, we report a universal split‐activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer‐mediated conformation switching, wherein target binding destabilizes an aptamer‐p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small‐molecule metabolite adenosine and the protein biomarker prostate‐specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN‐1), which undergo fluorescence decrease upon Cas12a‐mediated degradation. The system exhibits concentration‐dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer‐based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR‐Cas12a‐mediated detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University At Albany, State University of New York, Albany, New York, USA.
- The RNA Institute, University At Albany, State University of New York, Albany, New York, USA.
ORCID-Profile: Ram J Tharu, Yusha Imtiaz, Shubhajit Singha, Emmett Hanson, Reggie E Gold, Mehmet V Yigit
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Tharu, R. J., Imtiaz, Y., Singha, S., Hanson, E., Gold, R. E., Royzen, P., & Yigit, M. V. (2026). Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets. Small Methods. https://doi.org/10.1002/smtd.71075
Vancouver
Tharu RJ, Imtiaz Y, Singha S, Hanson E, Gold RE, Royzen P, et al. Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets. Small Methods. 2026. doi:10.1002/smtd.71075
BibTeX
@article{Tharu2026,
author = {Tharu, Ram J and Imtiaz, Yusha and Singha, Shubhajit and Hanson, Emmett and Gold, Reggie E and Royzen, Pavl and Yigit, Mehmet V},
title = {Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets},
journal = {Small Methods},
year = {2026},
doi = {10.1002/smtd.71075}
}
EUVIMED